Anthem Biosciences enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
45,257—
938938
51.151.1
44,370—
−887−887
₹789.90—
3,0943,094
1.7%1.7%
0.00×—
22.16×—
55.96×—
67.71×—
70.06×—
Reference items — trailing FY values
2,0022,124
793834
655700
—844
633633
—631
—211
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ANTHEM₹805.70

Anthem Biosciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABGLAXOAJANTPHARMIPCALABABBOTINDIAMEDANTAGLENMARKMcap ₹45,257 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization—45,257.4
- Cash, Equiv & ST Investments938.5938.5
+ Total Debt51.151.1
Enterprise Value—44,369.9
Net Debt (memo)-887.4-887.4
EV per Share—789.90
Total Capital3,093.63,093.6
Total Debt/Total Capital1.651.65
Total Debt/EV—0.00
EV/Sales—22.16
EV/EBITDA—55.96
EV/EBIT—67.71
EV/Free Cash Flow—70.06
Reference Items — Trailing FY Values
Sales2,124.32,002.3
EBITDA833.8792.9
EBIT699.7655.3
Operating Cash Flow844.5—
Free Cash Flow633.3633.3
FCFF (free cash flow to the firm)631.4—
Capital Expenditure211.2—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.